Dr. Reddy's Laboratories (DRREDDY) — Board Meeting

The board approved the re-appointment of G V Prasad as Whole-time Director and Co-Chairman & Managing Director for a five-year term starting January 30, 2026, with revised remuneration including a monthly salary of ₹14.40 lakhs and housing allowance of ₹7.20 lakhs. The AGM on July 24, 2025, will ratify cost auditor remuneration of ₹9 lakhs and appoint secretarial auditors for five years at ₹4 lakhs, while dividend of ₹8 per share remains payable by July 30, 2025, to eligible shareholders as of July 10, 2025.

📄 View Original Announcement (PDF)

📊 Stock Analysis — DRREDDY ✨ Ask AI About This

About Dr. Reddy's Laboratories Limited (DRREDDY)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,11,568.6 Cr P/E: 20.0 ROE: 16.6% ROCE: 19.7%

View full DRREDDY stock details →

📡 Get AI alerts when DRREDDY files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track DRREDDY — Free

💡 Ask AI about this filing

"How does this board meeting affect Dr. Reddy's Laboratories Limited's outlook?" "What did Dr. Reddy's Laboratories Limited announce on 30 June 2025?" "Is this positive or negative for DRREDDY?"

Ask AI Free →

📊 More DRREDDY filings

See all DRREDDY filings →

🔥 Also filed on 30 June 2025

TORNTPHARM Torrent Pharmaceuticals Limited Financial Results APOLLOHOSP Apollo Hospitals Enterprise Limited Corporate Action SHRIRAMFIN Shriram Finance Limited Corporate Action TECHM Tech Mahindra Limited Financial Results TITAN Titan Company Limited Annual Report APOLLOHOSP Apollo Hospitals Enterprise Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when DRREDDY files new disclosures

Track DRREDDY filings, board meetings, and corporate actions. Free email alerts at 5 PM.